Panacea Biotec Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has submitted a compliance certificate dated July 2, 2025, issued by its Registrar and Transfer Agent (RTA) Skyline Financial Services Private Limited, to NSE and BSE. The certificate confirms compliance with SEBI Regulation 74(5) for the quarter ended June 30, 2025. It verifies that all physical share certificates received for dematerialization during the quarter were duly listed on the stock exchanges, mutilated and cancelled, and the depository was recorded as the registered owner within the stipulated 15-day timeline. The filing was signed by Vinod Goel, Group CFO and Head Legal & Company Secretary. This is a standard quarterly procedural disclosure required of all listed companies whose shares are held in both physical and demat form.
This is a routine regulatory compliance filing with no material impact on shareholders, fundamentals, or stock price. Investors need not take any action — it simply confirms the proper processing of physical-to-demat share conversions during the April–June 2025 quarter.